CANADA LIFE ASSURANCE Co
InsurancePosition in FATE — Fate Therapeutics Inc
CIK 1046192
WINNIPEG, A2
Position in FATE
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$28,327
+$4,397 QoQ
Shares Held
23,606
-3.3% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CANADA LIFE ASSURANCE Co holds $291,124,718 across 78 Biotechnology names. FATE ranks #77 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
192,144 | $85,799,981 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
78,886 | $60,950,479 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,255 | $18,943,961 | |
| 4 | INCY |
Incyte Corp
|
111,609 | $10,504,639 | |
| 5 | INSM |
INSMED Inc
|
53,890 | $8,812,092 | |
| 6 | ARGX |
Argenx SE
|
11,567 | $8,446,801 | |
| 7 | MRNA |
Moderna, Inc.
|
148,181 | $7,527,594 | |
| 8 | EXEL |
Exelixis, Inc.
|
167,451 | $7,181,973 |
All Filings in FATE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $28,327 | 23,606 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $23,930 | 24,419 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $37,389 | 29,674 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $25,531 | 22,796 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $16,116 | 20,401 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $35,090 | 21,267 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $159,712 | 45,632 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $138,304 | 42,166 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $82,501 | 11,240 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $35,904 | 9,600 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $21,785 | 10,276 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $48,913 | 10,276 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $25,564 | 4,485 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $42,367 | 4,199 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $90,357 | 4,032 | Shares | Sole | 2022-11-01 | |
| 2022-03-31 | $151,280 | 3,902 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $257,385 | 4,399 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $257,172 | 4,339 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $376,581 | 4,339 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $358,904 | 4,353 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $390,726 | 4,297 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $171,751 | 4,297 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $147,430 | 4,297 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $95,436 | 4,297 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||